Compile Data Set for Download or QSAR
maximum 50k data
Found 58 Enz. Inhib. hit(s) with all data for entry = 2705
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Streptococcus pyogenes)
Quorex Pharmaceuticals

LigandPNGBDBM23585((3-Phenoxybenzoylamino)benzoic acid deriv., 24i | ...)
Affinity DataIC50:  3nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23587((3-Phenoxybenzoylamino)benzoic acid deriv., 33 | 2...)
Affinity DataIC50:  4nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Streptococcus pyogenes)
Quorex Pharmaceuticals

LigandPNGBDBM23587((3-Phenoxybenzoylamino)benzoic acid deriv., 33 | 2...)
Affinity DataIC50:  4nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23585((3-Phenoxybenzoylamino)benzoic acid deriv., 24i | ...)
Affinity DataIC50:  28nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Streptococcus pyogenes)
Quorex Pharmaceuticals

LigandPNGBDBM23586((3-Phenoxybenzoylamino)benzoic acid deriv., 31 | 2...)
Affinity DataIC50:  34nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Streptococcus pyogenes)
Quorex Pharmaceuticals

LigandPNGBDBM23584((3-Phenoxybenzoylamino)benzoic acid deriv., 24c | ...)
Affinity DataIC50:  50nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23584((3-Phenoxybenzoylamino)benzoic acid deriv., 24c | ...)
Affinity DataIC50:  56nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23586((3-Phenoxybenzoylamino)benzoic acid deriv., 31 | 2...)
Affinity DataIC50:  62nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23595((3-Phenoxybenzoylamino)benzoic acid deriv., 24d | ...)
Affinity DataIC50:  96nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23594((3-Phenoxybenzoylamino)benzoic acid deriv., 24b | ...)
Affinity DataIC50:  110nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23596((3-Phenoxybenzoylamino)benzoic acid deriv., 24e | ...)
Affinity DataIC50:  160nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23606((3-Phenoxybenzoylamino)benzoic acid deriv., 24p | ...)
Affinity DataIC50:  160nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23599((3-Phenoxybenzoylamino)benzoic acid deriv., 24h | ...)
Affinity DataIC50:  220nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23602((3-Phenoxybenzoylamino)benzoic acid deriv., 24l | ...)
Affinity DataIC50:  240nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23605((3-Phenoxybenzoylamino)benzoic acid deriv., 24o | ...)
Affinity DataIC50:  250nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23592((3-Phenoxybenzoylamino)benzoic acid deriv., 23i | ...)
Affinity DataIC50:  270nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23591((3-Phenoxybenzoylamino)benzoic acid deriv., 23h | ...)
Affinity DataIC50:  290nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23604((3-Phenoxybenzoylamino)benzoic acid deriv., 24n | ...)
Affinity DataIC50:  330nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23598((3-Phenoxybenzoylamino)benzoic acid deriv., 24g | ...)
Affinity DataIC50:  410nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23612(2-hydroxy-6-[(3-phenoxybenzene)amido]benzoic acid ...)
Affinity DataIC50:  410nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23601((3-Phenoxybenzoylamino)benzoic acid deriv., 24k | ...)
Affinity DataIC50:  470nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23603((3-Phenoxybenzoylamino)benzoic acid deriv., 24m | ...)
Affinity DataIC50:  570nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23600((3-Phenoxybenzoylamino)benzoic acid deriv., 24j | ...)
Affinity DataIC50:  790nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23581((3-Phenoxybenzoylamino)benzoic acid deriv., 23b | ...)
Affinity DataIC50:  1.10E+3nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23590((3-Phenoxybenzoylamino)benzoic acid deriv., 23g | ...)
Affinity DataIC50:  1.20E+3nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23572(2-{[3-(diethylsulfamoyl)-4-phenylbenzene]amido}ben...)
Affinity DataIC50:  1.60E+3nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23570(2-{[4-bromo-3-(diethylsulfamoyl)benzene]amido}benz...)
Affinity DataIC50:  1.60E+3nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23578(2-{[4-(cyclopentylmethoxy)-3-(diethylsulfamoyl)ben...)
Affinity DataIC50:  2.10E+3nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23597((3-Phenoxybenzoylamino)benzoic acid deriv., 24f | ...)
Affinity DataIC50:  2.10E+3nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23576(2-{[3-(diethylsulfamoyl)-4-(piperidin-1-yl)benzene...)
Affinity DataIC50:  2.20E+3nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Haemophilus influenzae)
Quorex Pharmaceuticals

LigandPNGBDBM23587((3-Phenoxybenzoylamino)benzoic acid deriv., 33 | 2...)
Affinity DataIC50:  2.40E+3nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23579((3-Phenoxybenzoylamino)benzoic acid deriv., 15 | 2...)
Affinity DataIC50:  2.70E+3nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23589((3-Phenoxybenzoylamino)benzoic acid deriv., 23f | ...)
Affinity DataIC50:  3.20E+3nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23614(2-benzoylamino benzoic acid deriv., 28h | 3-{3-[(2...)
Affinity DataIC50:  3.70E+3nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23580((3-Phenoxybenzoylamino)benzoic acid deriv., 23a | ...)
Affinity DataIC50:  3.80E+3nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Staphylococcus aureus)
Quorex Pharmaceuticals

LigandPNGBDBM23587((3-Phenoxybenzoylamino)benzoic acid deriv., 33 | 2...)
Affinity DataIC50:  3.80E+3nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23615(2-benzoylamino benzoic acid deriv., 28i | 4-{3-[(2...)
Affinity DataIC50:  4.40E+3nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23616(2-benzoylamino benzoic acid deriv., 28j | 2-{[3-(4...)
Affinity DataIC50:  5.00E+3nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23611(2-fluoro-6-[(3-phenoxybenzene)amido]benzoic acid |...)
Affinity DataIC50:  6.00E+3nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23577(2-{[3-(diethylsulfamoyl)-4-phenoxybenzene]amido}be...)
Affinity DataIC50:  6.10E+3nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23575(2-{[3-(diethylsulfamoyl)-4-fluorobenzene]amido}ben...)
Affinity DataIC50:  8.40E+3nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23613(2-[3-(Pyridin-4-yloxy)benzoylamino]benzoic acid | ...)
Affinity DataIC50:  1.00E+4nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Staphylococcus aureus)
Quorex Pharmaceuticals

LigandPNGBDBM23584((3-Phenoxybenzoylamino)benzoic acid deriv., 24c | ...)
Affinity DataIC50:  1.00E+4nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23607(3-Phenoxybenzoylamino deriv., 28a | 3-[(3-phenoxyb...)
Affinity DataIC50:  1.01E+4nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23574(2-{[3-(diethylsulfamoyl)-4-methoxybenzene]amido}be...)
Affinity DataIC50:  1.14E+4nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Staphylococcus aureus)
Quorex Pharmaceuticals

LigandPNGBDBM23586((3-Phenoxybenzoylamino)benzoic acid deriv., 31 | 2...)
Affinity DataIC50:  1.23E+4nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Haemophilus influenzae)
Quorex Pharmaceuticals

LigandPNGBDBM23586((3-Phenoxybenzoylamino)benzoic acid deriv., 31 | 2...)
Affinity DataIC50:  2.00E+4nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23593((3-Phenoxybenzoylamino)benzoic acid deriv., 24a | ...)
Affinity DataIC50:  2.20E+4nMAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Staphylococcus aureus)
Quorex Pharmaceuticals

LigandPNGBDBM23585((3-Phenoxybenzoylamino)benzoic acid deriv., 24i | ...)
Affinity DataIC50:  2.40E+4nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 3(Enterococcus faecalis)
Quorex Pharmaceuticals

LigandPNGBDBM23583((3-Phenoxybenzoylamino)benzoic acid deriv., 23d | ...)
Affinity DataIC50:  2.50E+4nMpH: 7.0 T: 2°CAssay Description:The potency of FabH inhibition (IC50) was determined using [3H]- or [14C]-radiolabeled substrates. This was accomplished at fixed concentrations of a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 58 total ) | Next | Last >>
Jump to: